Tag Archives: COVID-19

The annual African Union (AU) summit will be held this week for the first time since 2020 without COVID-19 restrictions. It coincides with the fragile return to peace in northern Ethiopia, the resurgence of widespread instability in the Great Lakes and the ongoing war in Ukraine, which continues to raise questions about African positions. The United Nations (UN) Security Council’s …

Melissa Hawkins is an epidemiologist and public health researcher at American University. She explains the way researchers calculate how well a vaccine prevents disease, what influences these numbers and how omicron is changing things.

The so-called vaccine politics that was being earlier peddled now falls short with reports and theories of hybrid warfare and a power-play taking place all but having fizzled out. 

The South Asian country is in the grip of the third wave of coronavirus but much of its population remains in denial mode, showing little respect for personal and public safety, stoking the infection rate to dangerous levels.

Travel restrictions will continue to emerge, end and evolve, dependent on context. As wealthier countries vaccinate their populations at rapid speed, less equipped countries continue to suffer severe outbreaks. International travel may soon require a COVID-19 “vaccination card.” New targeted travel bans could emerge.

Although awareness of food insecurity is growing, it is important to understand what is meant by the term and how it fits with other food access concepts, such as hunger and food sovereignty.

Limiting the size of gatherings helps reduce the potential for exposure. Controlling indoor environments in other ways can also be a highly effective strategy for reducing risk. This includes increasing ventilation rates to bring in fresh air and filtering existing air to dilute aerosol concentrations.

After a daunting year, and with more challenges ahead in 2021, upgrading your approach to emotions can be a drug-free mood booster.

Experts say that despite 95% efficacy of the COVID-19 vaccines, approximately 5% of people receiving the vaccination may still become infected.

The Oxford vaccine, based on a viral vector, is also cheaper (around US$4) than Pfizer and Moderna’s mRNA vaccines – around US$20 and $33, respectively. AstraZeneca has made a “no profit pledge”.